Compare GIII & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GIII | ATRC |
|---|---|---|
| Founded | 1956 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 2006 | 2005 |
| Metric | GIII | ATRC |
|---|---|---|
| Price | $30.71 | $28.80 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | $29.00 | ★ $51.17 |
| AVG Volume (30 Days) | 326.2K | ★ 706.1K |
| Earning Date | 06-05-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.29% | N/A |
| EPS Growth | N/A | ★ 74.74 |
| EPS | ★ 1.51 | N/A |
| Revenue | ★ $2,957,012,000.00 | $201,630,000.00 |
| Revenue This Year | N/A | $15.27 |
| Revenue Next Year | N/A | $12.21 |
| P/E Ratio | $20.87 | ★ N/A |
| Revenue Growth | N/A | ★ 15.40 |
| 52 Week Low | $20.33 | $26.62 |
| 52 Week High | $34.83 | $43.18 |
| Indicator | GIII | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 54.04 | 49.91 |
| Support Level | $28.28 | $28.03 |
| Resistance Level | $31.57 | $30.75 |
| Average True Range (ATR) | 0.85 | 1.36 |
| MACD | -0.02 | 0.12 |
| Stochastic Oscillator | 51.70 | 54.98 |
G-III Apparel Group Ltd is an apparel manufacturing company. The company makes a wide range of apparel, footwear, and accessories that sells under its own brands, licensed brands, and private-label brands. It has a substantial portfolio for licensed and proprietary brands, anchored by brands: DKNY, Donna Karan, Karl Lagerfeld, Karl Lagerfeld Paris, Vilebrequin, and others. The reportable segments of the company are Wholesale Operations and Retail Operations. The Wholesale operations segment includes sales of products under brands licensed by from third parties, and sales of products under its own brands and private label brands. The retail operations segment consists of Wilsons Leather, G.H. Bass, and DKNY retail stores. It derives majority of its revenue from Wholesale operations.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.